Trial Profile

A Phase I trial of MB-104 in patients with relapsed or treatment-resistant multiple myeloma

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 15 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MB 104 (Primary)
Indications Multiple myeloma
Focus Therapeutic Use

Most Recent Events

15 May 2019 New trial record
08 May 2019 According to a Mustang Bio media release, the company has announced that City of Hope cancer center has started enrolment in this trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com